GGRP

Glimpse GroupF

Nasdaq / Software & Services

At close

2026-06-02

View Chart

AI scenario view

RankAlpha Sentiment Codex

B+

Bull case

25%

Probability

Target price

$1.05

+46.5% vs current

Most likely

Base case

45%

Probability

Target price

$0.55

-23.2% vs current

B-

Bear case

30%

Probability

Target price

$0.25

-65.1% vs current

AI sentiment snapshot

Latest data as of 2026-04-15

AI commentary

This remains a low-conviction monitoring name. The strategic path around Brightline is real and primary-sourced, but current operating evidence is weak, the stock now trades below $1 with a Nasdaq compliance clock running, and the bull thesis depends more on corporate action than on clean underlying growth.

RankAlpha Sentiment Codex - 2026-04-15

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-06-30eventBrightline Interactive spinout / IPO decision windowHigh impact

Management said it filed a confidential S-1 for Brightline Interactive in early January 2026 and is targeting a potential IPO or alternative capitalization in the first half of calendar 2026; this is the clearest company-specific upside hook, but execution risk is high and management explicitly said there is no guarantee the IPO materializes. [#PR-2026-01-07] [#PR-2026-02-17] [#10Q-2026-02-17]

2026-08-13catalystCommercial proof that contracts can offset revenue compressionHigh impact

Recent wins include a mid-6-figure pharma follow-on contract announced February 25, 2026 and the previously disclosed $2+ million SpatialCore contract to be delivered over 12 months, but investors need evidence these programs and Foretell AI traction can translate into reported revenue after Q2 FY26 revenue fell 59% year over year to about $1.30 million. [#PR-2026-02-25] [#8K-2025-08-13] [#PR-2026-02-17]

2026-09-09eventNasdaq minimum bid-price cure or reverse-split pathHigh impact

Nasdaq notified the company on March 13, 2026 that it was below the $1.00 minimum bid requirement; the initial cure deadline is September 9, 2026, with possible extra time only if other listing tests are met and the company pursues a cure plan such as a reverse split. This is a hard dated overhang rather than a clean upside catalyst. [#8K-2026-03-13]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-04-15 • Updated nightlySource: Internal modelMethodology